RZLTRezolute, Inc.

Nasdaq rezolutebio.com


$ 2.63 $ 0.08 (3.13 %)    

Friday, 17-May-2024 15:57:43 EDT
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 2.64
$ 2.60
$ 0.00 x 0
$ 0.00 x 0
$ 2.60 - $ 2.68
$ 0.72 - $ 3.69
213,886
na
134.14M
$ 31.70
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 02-13-2024 12-31-2023 10-Q
3 11-13-2023 09-30-2023 10-Q
4 09-14-2023 06-30-2023 10-K
5 05-11-2023 03-31-2023 10-Q
6 02-10-2023 12-31-2022 10-Q
7 11-09-2022 09-30-2022 10-Q
8 09-15-2022 06-30-2022 10-K
9 05-12-2022 03-31-2022 10-Q
10 02-09-2022 12-31-2021 10-Q
11 11-12-2021 09-30-2021 10-Q
12 09-15-2021 06-30-2021 10-K
13 05-17-2021 03-31-2021 10-Q
14 02-10-2021 12-31-2020 10-Q
15 11-12-2020 09-30-2020 10-Q
16 10-13-2020 06-30-2020 10-K
17 05-14-2020 03-31-2020 10-Q
18 02-12-2020 12-31-2019 10-Q
19 11-14-2019 09-30-2019 10-Q
20 09-10-2019 06-30-2019 10-K
21 05-10-2019 03-31-2019 10-Q
22 02-14-2019 12-31-2018 10-Q
23 12-14-2018 09-30-2018 10-Q
24 10-15-2018 06-30-2018 10-K
25 05-15-2018 03-31-2018 10-Q
26 02-14-2018 12-31-2017 10-Q
27 11-14-2017 09-30-2017 10-Q
28 09-22-2017 06-30-2017 10-K
29 05-15-2017 03-31-2017 10-Q
30 02-02-2017 12-31-2016 10-Q
31 11-14-2016 09-30-2016 10-Q
32 09-28-2016 06-30-2016 10-K
33 05-16-2016 03-31-2016 10-Q
34 02-16-2016 12-31-2015 10-Q
35 11-16-2015 09-30-2015 10-Q
36 09-28-2015 06-30-2015 10-K
37 05-15-2015 03-31-2015 10-Q
38 02-17-2015 12-31-2014 10-Q
39 11-12-2014 09-30-2014 10-Q
40 09-30-2014 06-30-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-rezolute-maintains-14-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Rezolute (NASDAQ:RZLT) with a Buy and maintains $14 price target.

 rezolute-q3-2024-gaap-eps-034-misses-030-estimate

Rezolute (NASDAQ:RZLT) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.30) by...

 jmp-securities-reiterates-market-outperform-on-rezolute-maintains-7-price-target

JMP Securities analyst Jason Butler reiterates Rezolute (NASDAQ:RZLT) with a Market Outperform and maintains $7 price target.

 jmp-securities-reiterates-market-outperform-on-rezolute-maintains-7-price-target

JMP Securities analyst Jason Butler reiterates Rezolute (NASDAQ:RZLT) with a Market Outperform and maintains $7 price target.

 jonestrading-initiates-coverage-on-rezolute-with-buy-rating-announces-price-target-of-10

JonesTrading analyst Catherine Novack initiates coverage on Rezolute (NASDAQ:RZLT) with a Buy rating and announces Price Tar...

 maxim-group-initiates-coverage-on-rezolute-with-buy-rating-announces-price-target-of-8

Maxim Group analyst Jason McCarthy initiates coverage on Rezolute (NASDAQ:RZLT) with a Buy rating and announces Price Target...

 commscope-holding-and-2-other-stocks-under-3-insiders-are-buying

The Dow Jones index closed higher by around 0.1% on Thursday. When insiders purchase or sell shares, it indicates their confide...

 17m-bet-on-this-healthcare-stock-check-out-these-4-penny-stocks-insiders-are-aggressively-buying

The Dow Jones index closed higher by over 300 points on Tuesday. When insiders purchase or sell shares, it indicates their conf...

 15m-bet-on-this-penny-stock-check-out-these-4-stocks-under-5-insiders-are-aggressively-buying

The Dow Jones index closed lower by around 0.2% on Friday. When insiders purchase or sell shares, it indicates their confidence...

 hc-wainwright--co-reiterates-buy-on-rezolute-maintains-14-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Rezolute (NASDAQ:RZLT) with a Buy and maintains $14 price target.

 lumen-technologies-and-3-other-stocks-under-3-insiders-are-buying

The Dow Jones index closed lower by around 100 points on Tuesday. When insiders purchase or sell shares, it indicates their con...

 charles--colvard-and-3-other-stocks-under-2-insiders-are-buying

The Dow Jones index closed higher by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confid...

 rezolute-and-3-other-penny-stocks-insiders-are-buying

The Dow Jones index closed lower by more than 60 points on Tuesday. When insiders purchase or sell shares, it indicates their c...

 hc-wainwright--co-reiterates-buy-on-rezolute-maintains-14-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Rezolute (NASDAQ:RZLT) with a Buy and maintains $14 price target.

 rezolute-q2-eps-027-beats-030-estimate

Rezolute (NASDAQ:RZLT) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.30) by 1...

 rezolute-expands-leadership-team-with-appointment-of-daron-evans-ms-mba-as-chief-financial-officer

Rezolute, Inc. (NASDAQ:RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapie...

 rezolute-receives-innovation-passport-designation-from-the-uk-innovative-licensing-and-access-pathway-steering-group-for-rz358-in-the-treatment-of-hypoglycemia-due-to-congenital-hyperinsulinism

Rezolute, Inc. (NASDAQ:RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapie...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION